Wellington announces a new investment in SciRhom

Wellington

SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases.

The upsized and oversubscribed Series A financing round will be used to drive the lead development program toward clinical proof-of-concept and to broaden the therapeutic value of the proprietary iRhom2 strategy.

Munich, Germany, July 9, 2024 – SciRhom GmbH, a biopharmaceutical company pioneering the development of first-in-class therapeutic iRhom2 antibodies, announced today the closing of a EUR 63 million (USD 70 million) Series A financing round. The round was co-led by Andera Partners, Kurma Partners, Hadean Ventures, MIG Capital, and Wellington Partners, with participation from new investor Bayern Kapital and existing investors including High-Tech Gründerfonds (HTGF) and PhiFund Ventures from New York, USA. The new funds will be used to accelerate and broaden the impact of the company’s innovative therapeutic strategy in autoimmune disorders. The first clinical study evaluating SR-878, a highly specific monoclonal antibody for iRhom2, is expected to start dosing in the second half of 2024.

SciRhom was founded with the mission to provide a new treatment paradigm for autoimmune diseases and potentially other indications by selectively addressing TACE/ADAM17, a master switch for various autoimmune disease-relevant signaling pathways, via iRhom2. The SciRhom team collaborated closely with co-founders Prof. Carl Blobel and Hospital for Special Surgery (HSS), the world’s leading academic medical center specialized in Rheumatology and musculoskeletal health, where Prof. Blobel serves as Director of the Arthritis and Tissue Degeneration Program. He has made seminal contributions to the understanding of how iRhom2 controls the activity of TACE/ADAM17 in inflammation and autoimmune diseases. SciRhom designed its most advanced development candidate SR-878 to simultaneously block several pro-inflammatory and disease-driving pathways, including TNF-alpha, IL-6R, and EGFR signaling, while preserving other vital functions dependent on TACE/ADAM17.

This unique ability to attack multiple cytokines and to potentially promote immune tolerance through restoring beneficial TNFR2 signaling, and regulatory T-cell expansion promises tohave a transformative effect in patients across a wide range of autoimmune diseases. Moreover, the selective targeting of iRhom2 is expected to have a favorable safety profile.

„Since its foundation, SciRhom has applied rigorous science to establish a leading position in iRhom2-targeting biopharmaceuticals including a comprehensive IND/CTA-enabling data and CMC package and strong patent protection. Now is the time to shift gears and accelerate our novel and potentially groundbreaking therapeutic strategy toward clinical proof-of-concept and beyond to reach patients in need of better autoimmune treatments,” commented co-founder Dr. Jens Ruhe, Managing Director & COO of SciRhom.

Based on positive preclinical data sets generated in vitro and in established animal models of rheumatoid arthritis (RA) and inflammatory bowel disease (IBD), SciRhom has advanced its first program to a Phase 1-ready stage. As announced on June 12th, 2024, the first CTA approval was achieved paving the way for initiating a first clinical study in Austria in the second half of 2024. The study aims to evaluate safety in healthy volunteers and provide initial evidence of clinical activity in the second part of the study.

Dr. Jan Poth, Managing Director & CEO of SciRhom added: “We are excited to have attracted such a high-caliber international consortium of investors and appreciate our existing shareholders backing SciRhom in this crucial period of its development. We look forward to collaborating with our new as well as existing partners and board members to bring a differentiated therapeutic option to patients and address the unmet medical need for much more effective and safe treatments for autoimmune disorders.”

“We are delighted to have supported SciRhom from its inception all the way to CTA approval and are now looking forward to working with the new investors to take SciRhom‘s lead antibody into the clinic,” commented Hans-Ulrich Rabe, current Chairman of the Advisory Board and one of the four founding investors who jointly invest in biotech start-ups via their investment platform Ventura Ace.

In conjunction with this investment, Dr. Olivier Litzka from Andera Partners, Dr. Peter Neubeck from Kurma Partners, Dr. Georgina Askeland from Hadean Ventures, Dr. Fei Tian from MIG Capital and Dr. Varun Gupta from Wellington Partners will join SciRhom’s Board of Directors.

They together stated “iRhom2 is a key driver of inflammation and SR-878 offers a first-in-class opportunity for multi-pathway inhibition as well as promoting immune and tissue homeostasis. This approach has a transformative potential for patients with autoimmune diseases that are currently difficult to treat with existing drugs. SciRhom is led by a highly experienced and dedicated team of people who we strongly believe will be able to drive SR-878 to clinical validation.”

The team of SNP Schlawien Partnerschaft led by Dr. Thomas Schmid acted as legal advisor to SciRhom in the transaction.

About iRhom2
TACE (TNF-alpha converting enzyme, also known as ADAM17) controls several major signaling pathways, including TNF-alpha, IL-6R, and EGFR signaling. TACE is therefore widely accepted as a potential target to block pro-inflammatory pathways, but direct inhibition of TACE causes severe side effects. The more recent discovery that iRhom2 (inactive Rhomboid 2, RHBDF2) simultaneously and very specifically regulates the TACE-dependent release of TNF-alpha and other pro-inflammatory molecules from immune cells provides the exciting opportunity to target the disease-driving activities of TACE while preserving its other vital functions. Given the pivotal role of iRhom2, numerous new research studies have recently highlighted the therapeutic potential of targeting iRhom2 to treat immunological and inflammatory diseases and beyond, including oncological, infectious, and metabolic diseases.

About SciRhom GmbH
At SciRhom, we are translating world-leading expertise in the TACE/ADAM17 pathway and its central role in autoimmunity and other indications into breakthrough biopharmaceuticals. We are developing proprietary and first-in-class iRhom2-targeting therapies and are accelerating our lead antibody program SR-878 into and through clinical development. With strong support from international lead investors Andera Partners, Kurma Partners, Hadean Ventures, MIG Capital, Wellington Partners, as well as Bayern Kapital and current shareholders, SciRhom aims to push the boundaries in autoimmune medicine.

For further information, please visit www.SciRhom.com

Contact
SciRhom GmbH
Dr. Jan Poth
Email: info@SciRhom.com

Valency Communications
Mario Brkulj
Email: mbrkulj@valencycomms.eu

Categories: News

Tags:

Closing of the Acquisition of Next-Generation 9-1-1 Pioneer INdigital

Novacap

Novacap is pleased to announce the successful completion of its previously-announced acquisition of Communications Venture Corporation, Inc. (DBA “INdigital”).

“We are thrilled to formally welcome INdigital, a pioneer in Next Generation 9-1-1 services, into the Novacap family,” stated François Laflamme, Senior Partner at Novacap. “This acquisition emphasizes our commitment to investing in technologies that enhance public safety. INdigital’s innovative solutions and solid market position perfectly aligns with our investment strategy. Our aim is to collaborate with the INdigital team to foster their growth in the NG911 sector.”

“We are excited to have achieved this significant milestone,” expressed Mark Grady, Founder and CEO of INdigital. “We are eager to work closely with the Novacap team to further innovate and broaden our capabilities to deliver state-of-the-art, lifesaving technologies globally.”

INdigital is the second portfolio company of Novacap’s Digital Infrastructure platform.

Houlihan Lokey served as exclusive financial advisor and Dentons served as legal advisor to INdigital.

Foley & Lardner served as legal advisor to Novacap.

Categories: News

Tags:

Nasuni Announces Majority Investment Led by Vista Equity Partners at $1.2 Billion Valuatio

Vista Equity

TCV and KKR also Participate as New Investors

BOSTONJuly 9, 2024 /PRNewswire/ — Nasuni, a leading enterprise data platform for modern hybrid cloud environments, today announced a strategic growth investment led by Vista Equity Partners, a global investment firm focused exclusively on enterprise software, data, and technology-enabled businesses. Vista will be joined by TCV and KKR in the new investment, which values Nasuni at approximately $1.2 billion.

The investment will build on Nasuni’s strong momentum disrupting the legacy storage industry to further accelerate product innovation and commercial expansion in the global hybrid cloud market. Further terms of the transaction were not disclosed.

“At Nasuni, we care first and foremost about the success of our customers, partners, and employees,” said Paul Flanagan, CEO of Nasuni. “We are maniacal about our commitment to delivering quality in every aspect of our business and interaction with our customers. This investment and our strategic partnership with Vista, TCV, and KKR will allow us to build upon that commitment, scale with purpose and continue to innovate as we look to take Nasuni to the next level.”

Nasuni’s success to-date includes award winning technology, top decile customer retention rates, industry leading NPS scores, and a consistent 30% growth rate in a market that is rapidly expanding with the advent of hybrid cloud and AI. Nasuni’s data platform is used by over 850 companies spanning 70 countries, and is in use by some of the largest enterprises in the manufacturing, consumer goods, and energy industries.

“Nasuni’s platform offers a highly differentiated approach to consolidating, protecting, and managing data at scale with performance that is critical to supporting AI applications and other high-volume data use-cases,” said Martin Taylor, Co-Head of Vista’s Foundation Fund and Senior Managing Director. “We are thrilled to partner with the Nasuni team as they work to help businesses optimize their expanding and complex data needs with solutions that are fast, secure, and highly cost-effective.”

BofA Securities served as the exclusive financial advisor and Goodwin Proctor LLP served as legal advisor to Nasuni. Kirkland & Ellis LLP served as legal counsel to Vista and TCV. KKR is making the investment through its Next Generation Technology III Fund.

About Nasuni

Nasuni is a scalable data platform for enterprises facing an explosion of unstructured data in an AI world.

The Nasuni File Data Platform delivers effortless scale in hybrid cloud environments, enables control at the network edge, and meets the modern enterprise expectation for insight- and AI-ready data. It simplifies file data management while increasing storage access and performance. Its best-in-class file recovery protects customers against a range of cyber threats and eliminates the need for specialized backup and disaster recovery – all while cutting the cost of infrastructure by up to 65%.

Organizations worldwide rely on Nasuni, spanning across the manufacturing, construction, energy, consumer goods, and public sectors. Nasuni’s corporate headquarters is in Boston, Massachusetts, and the company delivers services to over 70 countries. For more information, visit www.nasuni.com.

About Vista Equity Partners

Vista is a leading global investment firm with more than $100 billion in assets under management as of December 31, 2023. The firm exclusively invests in enterprise software, data and technology-enabled organizations across private equity, permanent capital, credit and public equity strategies, bringing an approach that prioritizes creating enduring market value for the benefit of its global ecosystem of investors, companies, customers and employees. Vista’s investments are anchored by a sizable long-term capital base, experience in structuring technology-oriented transactions and proven, flexible management techniques that drive sustainable growth. Vista believes the transformative power of technology is the key to an even better future – a healthier planet, a smarter economy, a diverse and inclusive community and a broader path to prosperity. Further information is available at vistaequitypartners.com. Follow Vista on LinkedIn, @Vista Equity Partners, and on X, @Vista_Equity.

About TCV

For nearly thirty years, TCV has partnered with global, category-defining, technology companies as a leading growth equity investor. Leveraging its deep industry expertise and strategic resources, TCV’s mission is to provide long-term capital and support to high-quality management teams across their growth journey. Since its founding in 1995, TCV has invested over $20 billion in more than 350 technology companies worldwide and has supported over 150 IPOs and strategic acquisitions, making it one of the most active technology investors. Select investments include Airbnb, AxiomSL, Built, CCC Intelligent Solutions, Celonis, Clio, Cradlepoint, ETQ, ExactTarget, Expedia, Facebook, Fandango, Genesys Software, GoDaddy, GoFundMe, HomeAway, Miro, Netflix, Nubank, OneSourceVirtual, Prodege, Qonto, Relex, Revolut, SilverPeak, Splunk, Sportradar, Spotify, Toast, Twillio, and Zillow. TCV has a global presence in Menlo Park, New YorkLondon and Melbourne. For more information on TCV and its investments, visit tcv.com.

About KKR
KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing worldclass people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at www.globalatlantic.com.

Media Contacts

Nasuni
Kristin Concannon
kconcannon@nasuni.com
617-416-2873

Vista Equity Partners
Brian W. Steel
media@vistaequitypartners.com
212-804-9170

TCV
marketing@tcv.com

KKR
Liidia Liuksila
media@kkr.com

SOURCE Nasuni

Categories: News

Tags:

Convocation for the extraordinary general meeting of Gimv on July 31, 2024

GIMV

Topic: Shareholders meeting

Today Gimv published the convocation for the extraordinary general meeting to be held on July 31, 2024 at 10:30 a.m. at Gimv’s registered office.

At the extraordinary general meeting (EGM) of June 26, 2024, the required attendance quorum of 50% of the capital was not reached. Gimv therefore published today the notice convening a second EGM to be held on July 31, 2024 at Gimv’s registered office. This EGM will be able to validly deliberate and decide regardless of the number of shares present or represented.

The agenda of this EGM concerns the amendment of the articles of association in function of the change in reference shareholding and subsequent update regarding governance, more specifically regarding the composition of the board of directors (1/3 of the total number of directors nominated by WorxInvest and at least a majority of independent directors) and advisory committees (minimum two members in each committee nominated by WorxInvest and in each case a majority of independent directors).

All information relating to this EGM can be consulted on the Gimv website:

https://www.gimv.com/en/investors/shareholder-meetings

 

Read the full document

 

Gimv

Karel Oomsstraat 37, 2018 Antwerpen, Belgium

www.gimv.com

Categories: News

Ratos Company HENT wins billion-krone contract for two stations on the new Fornebubanen metro line in Oslo

Ratos

The construction company HENT and Fornebubanen have signed an agreement for the construction of the two stations Fornebuporten and Flytårnet on the new Fornebubanen metro line in Oslo, Norway. The contract is valued at NOK 1.67 billion.

The contract covers the construction of two metro stations and consists of concrete and platform works, access buildings and technical installations such as escalators, lifts, and technical rooms. Certain outdoor work and landscape architecture are also included in the contract.

“HENT has added another exciting and prestigious contract to its already impressive order book. The company is a community builder in its truest sense. Thanks to our unique experience built up over many years, we can contribute to the residents of Oslo being able to travel climate smart in the future,” says Christian Johansson Gebauer, Chairman of the Board of HENT and President, Business Area Construction & Services, Ratos.

“This agreement is an important milestone for HENT. We have been working on the project for a long time and have several good experiences from similar projects in the interface between infrastructure and construction. The project involves several challenges in terms of planning and operational implementation in combination with complex building structures, high quality requirements and ambitious environmental requirements. We thank Fornebubanen for their trust, and look forward to a good collaboration in the coming years,” says Jan Jahren, CEO, HENT.

HENT delivered the best offer based on price, environment and quality. The work will start in September this year and is expected to be completed in 2027.

About HENT
HENT is a leading construction company that mainly works with new construction of public and commercial real estate. HENT focuses on project development, project management and purchasing. Its projects are carried out with their own project administration and in collaboration with a knowledgeable network of quality-assured subcontractors. They conduct projects throughout Norway and in selected segments in Sweden and Denmark.

Categories: News

Tags:

Ratos Company Semcon’s climate target approved by the Science Based Target initiative

Ratos

Semcon’s climate target has now been validated and approved by the Science Based Targets initiative (SBTi).

“We are proud that Semcon has now had its climate goal approved by SBTi. It shows that Semcon’s own climate work is scientifically based, and it is another important piece of the puzzle in Ratos’s group-wide sustainability work. It is a result of purposeful work at Semcon and a conviction that everyone needs to contribute to the journey towards net-zero” says Josefine Uppling, Vice President Communication & Sustainability, Ratos.

Semcon’s near-term science-based target, which has now been approved by the SBTi, is the following:
Semcon commits to reduce absolute scope 1, 2, and 3 GHG emissions 50% by 2030 from a 2019 base year. (The target boundary includes biogenic land-related emissions and removals from bioenergy feedstocks.)

“Semcon has a strong combination of engineering, digital and sustainability expertise, and we support our customers in the development of green technologies, the transition to net-zero and circular value chains, and much more. While our largest possibility to contribute to the shift to a net-zero society is through our customer projects, we ourselves must do what is required of all companies and organisations right now. The approval of our climate target by the SBTi validates that our commitment is in line with the 1.5°C ambition,” says Markus Granlund, CEO of Semcon.

In June 2021, Semcon committed to setting climate targets in line with the 1.5 °C ambition with the SBTi. Due to Ratos’s acquisition of Semcon in 2022, Semcon’s proposal for near-term target was then submitted in December 2022. The target was resubmitted in November 2023 as the Group structure changed following the divestment of Semcon’s Product Information business area (today independent company Aleido).

Since 2021, Semcon’s overall commitment is to halve emissions by 2030 and be net-zero by 2040, with 2019 as the base year. It’s largest sources of emissions are linked to employee commuting, business travel and purchased goods and services.

About Semcon
Semcon is an international technology partner for companies and organisations in transformation. The company combines engineering expertise, digital services and sustainability know-how in a unique offering for product, production and service development. Always based on human needs and behaviour. Their experts and cross-functional teams make their customers more competitive and improve the user experience and sustainability of their solutions. Because a sustainable future requires innovative thinking and new perspectives. Semcon has approximately 1,400 employees in more than 20 offices in Sweden, Norway and Brazil. Read more at www.semcon.com.

About the Science Based Target initiative
The Science Based Targets initiative (SBTi) is a collaboration between CDP, the United Nations Global Compact, World Resources Institute (WRI) and the World Wide Fund for Nature (WWF). The SBTi defines and promotes best practice in science-based target setting and independently assesses companies’ targets. To read more, visit www.sciencebasedtargets.org.

For more information, please contact:
Josefine Uppling, VP Communication & Sustainability, Ratos, +46 76114 54 21
Markus Granlund, President and CEO, Semcon, +46 31 721 03 06


Categories: News

Tags:

IK Partners enters exclusive negotiations to sell Mademoiselle Desserts to the Emmi Group

IK Partners

IK Partners (“IK”) is pleased to announce that the IK VIII Fund has entered into exclusivity to sell its stake in Mademoiselle Desserts (“the Company”), a leading European manufacturer of frozen pastries, to the Emmi Group (“Emmi”). Financial terms of the transaction are not disclosed.

Established in 1984 and headquartered in Montigny-le-Bretonneux in France, Mademoiselle Desserts has rapidly grown to become a leading European manufacturer of premium frozen pastries, including mini beignets, mini muffins, choux-based pastries, tarts, flans and pastry bases.

From its 12 production facilities in France, Benelux and the UK, Mademoiselle Desserts serves over 900 customers in more than 45 countries globally. The Company employs approximately 2,000 people who collaborate closely with its customers to develop bespoke desserts meeting the highest food standards.

In partnership with IK since 2018, Mademoiselle Desserts has achieved several strategic objectives and successfully executed the acquisitions of: Pâtisserie Michel Kremer in 2018; Les Délices Des 7 Vallées in 2019; Planète Gourmet in 2021; and Galana in 2023. These acquisitions have enabled the Company to expand internationally, particularly in the US and Europe, while enhancing its product portfolio towards mini products.

IK also supported the Company with an operational excellence programme centred around purchasing, site specialisation and logistics. Investments in production lines were also made to further expand the business’s capacity. These initiatives, coupled with the expertise of the management team, have resulted in substantial growth and expansion for the group.

Didier Boudy, CEO of Mademoiselle Desserts, commented: “We would like to thank IK for all their support in the past six years. This period has seen us navigate several significant global crises, but we have managed to emerge as a stronger business through the dedication of our own employees and the expertise and financial backing of IK. We are very excited about the next chapter which will see us working closely with Emmi.”

Rémi Buttiaux, Managing Partner at IK and Advisor to the IK VIII Fund, said: “Since investing in Mademoiselle Desserts in 2018, we have been extremely impressed with the professionalism and expertise of the entire team. Together, we have implemented organic growth initiatives and executed several bolt-on acquisitions, solidifying the Company’s position as one of Europe’s leading manufacturers of frozen pastries and desserts. We wish Didier and his team continued success for the next stage of their already impressive growth story.”

For further questions, please contact:

IK Partners
Vidya Verlkumar
Phone: +44 (0) 7787 558 193
vidya.verlkumar@ikpartners.com

Mademoiselle Desserts

Mademoiselle Desserts is a leading frozen bakery player in Europe. Founded in 1984, the Group has grown through an active build-up strategy in France, the UK and Netherlands. It operates 12 production sites and employs approximately 2,000 people. For more information, visit http://www.mademoiselle-desserts.com

IK Partners

IK Partners (“IK”) is a European private equity firm focused on investments in the Benelux, DACH, France, Nordics and the UK. Since 1989, IK has raised more than €16.5 billion of capital and invested in over 180 European companies. IK supports companies with strong underlying potential, partnering with management teams and investors to create robust, well-positioned businesses with excellent long-term prospects. For more information, visit ikpartners.com

Read More

Categories: News

Tags:

BSI Software partners with new investor Bregal Unternehmerkapital, to continue its customer-oriented growth strategy in Europe

Bregal unternehmerkapital
Funds advised by Bregal Unternehmerkapital partner with leading provider of innovative CRM and CX software in its focus industries. The transaction marks a full exit of Capvis Equity V LP. This new partnership is built to support the BSI team in the continuation of its customer-orientated growth strategy, expansion in Europe and the continuous expansion of the software platform. The existing team of founders, management and employees will continue to have a significant stake in BSI.
Baden, 04.07.2024

Funds advised by Bregal Unternehmerkapital (“BU”) acquire a majority stake in the Baden-based company, BSI Software AG (“BSI”), a leading provider of software solutions for customer relationship management (“CRM”) and customer experience (“CX”) in its focus industries.

As part of BU’s investment, Capvis Equity V LP, the fund advised by the Swiss investment company Capvis AG (“Capvis”), sells its shares after four years of successful partnership with BSI. The BSI management team remains invested and will continue its successful work together with BU.

Holistic software platform for CRM & CX
For more than 25 years, BSI has been providing innovative software solutions for companies that strive to lead the way in digitalisation and customer centricity. More than 500 employees work “with heart and soul” for their customers and the “BSI Customer Suite”, which now comprises seven integrated products. The modern cloud solution is primarily used by sophisticated customers from the financial services, insurance, energy & utility, and retail sectors to digitise relationships with millions of end customers in a customer-oriented, efficient and intelligent way. The BSI Customer Suite comes with an Industry Cloud that integrates in-depth industry knowledge with specific processes and regulations into the software. A Existing IT systems are always fully integrated via various standard connectors to enable a high degree of automation and a consistent data flow. The software and data are stored in Swiss or German data centres.

Markus Brunold, CEO of BSI comments: ”BSI connects people and software. The BSI Customer Suite combines customer focus and industry expertise based on a sophisticated no-code/low-code platform. With this recipe for success, we are continuing our growth strategy in Europe to inspire more customers.”

Successful partnership with Capvis in recent years 
When Capvis partnered with BSI in 2020, the aim was to continue BSI’s success story and at the same time provide further impulses for growth. Over the past four years, new software products have been developed, state-of-the-art cloud architectures rolled out, and the industry modules expanded. BSI has also been able to acquire three companies and expand the functionality of the Customer Suite with Snapview (GDPR-compliant video consulting), inSign (electronic signatures of the highest security level) and Riskine (software solution for advisory processes at banks and insurance companies).

André Perwas, Partner at Capvis, adds, “We were delighted when the founders and management chose Capvis in 2020. We have achieved a great deal in this partnership and are convinced of BSI’s success in the next chapter of its growth.”

Partnership with BU continues to focus on customer-centred growth and supports BSI’s expansion in Europe
With BU, BSI has gained a partner with a long track record of experience in the software sector. BU is the largest mid-cap investor headquartered in the DACH region and has been active in the investment area since 2015. BU has offices in Zug, Munich and Milan.

”Of course, our customers and our products will remain the focus of our further growth strategy,” explains Markus Brunold, CEO of BSI, adding, “with BU, we can simultaneously drive forward internationalisation and expand in our focus industries within Europe”.

Chris Rusche, co-founder and board member of BSI, adds, “The growing size allows us to continue to invest in our employees and products. All our customers benefit from BSI’s success with a strong, comprehensive, European software platform for CRM and CX”.

Philipp Struth, Partner at BU, commented, “BSI convinced us not only with its innovative product portfolio but, above all, with its unique corporate culture, which has turned a large part of its workforce into real co-entrepreneurs. At BU, we feel honoured to be able to help shape and support BSI’s future growth.”

The parties have agreed not to disclose the financial terms of the transaction. The completion of the transaction is still subject to the approval of the relevant authorities.

About BSI
With its Customer Suite, the Swiss software company BSI offers a holistic, AI-supported platform for the digitalisation of customer relationships. BSI provides everything that an excellent customer experience needs for banking, insurance, retail and energy & utilities. In addition to its many years of industry expertise, this also includes BSI’s CRM system with a generative 360° customer view and a BSI Companion. Around 230 corporate customers use BSI’s software to reach their more than 150 million end customers throughout Europe. Since its foundation in Switzerland in 1996, the company has established itself as the market leader in its focus industries in the DACH region. Its customers include renowned companies such as ADAC, the Raiffeisen Banking Group, Signal Iduna, PostFinance and Merkur Software and people working together – that’s what BSI stands for. www.bsi-software.com  

About Capvis
Capvis AG, Baar, Switzerland, is the exclusive adviser of the Capvis funds that primarily acquire majority stakes in leading medium-sized technological firms. Its activity is founded on its longstanding experience in creating local and global market leaders in the fields of healthcare, industrial technology, and advanced services & software from family or entrepreneurial owned companies. Close cooperation with strong management teams ensures that the potential of companies is developed to the full while creating long-term values. Capvis has a track record of more than 30 years in private equity and invested more than EUR 4 billion in 63 companies. The remarkable number of 10 IPOs documents the quality of the investments managed and developed by Capvis. www.capvis.com

About Bregal Unternehmerkapital
Bregal Unternehmerkapital (“BU”) is a leading investment firm with offices in Zug, Munich, and Milan. With €7.0bn in capital raised to date, BU is the largest mid-cap investor headquartered in the DACH region. The funds advised by BU invest in mid-sized companies based in Germany, Switzerland, Italy, and Austria. With the mission to be the partner of choice for entrepreneurs and family-owned businesses, BU seeks to partner with market leaders and “hidden champions” with strong management teams and outbreak potential. Since its founding in 2015, the funds advised by BU have invested over €3.0 billion in more than 100 companies with more than 27,000 employees. Thereby, more than 7,700 jobs have been created. BU supports entrepreneurs and families as a strategic partner to develop, internationalize, and digitize their businesses, while helping them generate sustainable value on a responsible basis with the next generation in mind. www.bregal.ch

Download Press Release

Press contact

Ira Wülfing / Florian Bergmann
IWK Communication Partner
bregal@iwk-cp.com
+49 89 2000 30 30

Sandra Schäfer
Head of Marketing & Communications
sandra.schaefer@bregal.de
+49 89 435 715 007


Categories: News

Laure Delabeye appointed Director of Human Resources and Services at Wendel

Wendel

Wendel announces the appointment of Laure Delabeye as Director of Human Resources and Services for the
Wendel Group. In this role, she will be in charge of Human Resources, General Resources and IT services.

Biography of Laure Delabeye
After graduating from EFAP (École des nouveaux métiers de la communication) and IGS
(Institut de Gestion Sociale), Laure Delabeye, 54 years old, worked over 25 years as
Human Resources Director in French and international environments, mainly in the
Finance and Insurance sectors.

Before joining Wendel, Laure spent 14 years as Human Resources Manager in AXA
Group operating entities, supporting their transformation. Laure then joined the American
bank JP Morgan as HR Director for France, before extending her responsibilities to Spain
and Portugal. For 7 years, she acquired expertise in leading teams in multicultural and sensitive contexts, and
dealt in particular with the impacts of Brexit from an HR point of view on a European level. From 2019 to 2021,
Laure was Global Head of Human Resources for Natixis Investment Banking.

In 2021, Laure made a turning point in her career by becoming a certified coach (HEC Global International
Executive coaching, ICF accredited). She set up Oyat Coachsulting to support senior executives facing new
challenges.

Categories: People

Gimv announces strategic investment in Curana, leading bicycle components manufacturer

GIMV

Topic: Investment

Gimv is pleased to announce its strategic investment in Curana, a leading developer and manufacturer of high-end bicycle components, specialising in fenders, chain guards and dress guards. Based in Ardooie, Belgium, Curana is renowned for its design and innovation capabilities, providing custom-built solutions for top-tier bicycle manufacturers.

Gimv’s investment in Curana underscores its commitment to the sector of sustainable mobility and lifestyle consumer products and its confidence in Curana’s potential for continued success.

In partnership with Gimv, Curana intends to professionalise its organisation and accelerate its international growth strategy, building upon its reputation as the go-to partner for top-tier bicycle manufacturers. This investment comes at a pivotal moment for Curana, following the untimely passing of its owner, Dirk Vens, during the investment process. Gimv is committed to honouring Dirk’s legacy by continuing to build on the robust foundation he established. Gimv is investing alongside Jean-Charles Malherbe, the newly appointed buy-in CEO, and management to drive this next phase of growth for Curana.

Jean-Charles Malherbe, CEO Curana, states: “Curana has always been at the forefront of design and innovation in the bicycle components industry. Our small but dedicated team is passionate about delivering tailor-made solutions that meet the unique needs of our customers. I am honoured to lead Curana into its next chapter, building on Dirk Vens’ remarkable legacy. Together with Gimv, we will continue to push the boundaries of innovation and maintain the high standards of quality and customer satisfaction for which Curana is known.”

David De Peuter, Partner Gimv Consumer, adds: “Curana is a perfect fit for Gimv’s consumer investment strategy, particularly given its strong presence in the bicycle and e-bike sectors. We are confident in the mid- and long-term prospects for the bicycle industry driven by robust and favourable fundamental trends. We see tremendous potential in Curana’s innovative approach and high-quality products. Our goal is to guide Curana in its next growth phase, ensuring that the company continues to deliver exceptional value to its customers and partners.

Financial details of the transaction will not be disclosed.

 

Read the full document

Categories: News

Tags: